URTICARIA and Mirtazapine


URTICARIA Symptoms and Causes

Hives are red and sometimes itchy bumps on your skin. An allergic reaction to a drug or food usually causes them. Allergic reactions cause your body to release chemicals that can make your skin swell up in hives. People who have other allergies are more likely to get hives than other people. Other causes include infections and stress.

Hives are very common. They usually go away on their own, but if you have a serious case, you might need medicine or a shot. In rare cases, hives can cause a dangerous swelling in your airways, making it hard to breathe - which is a medical emergency.

Check out the latest treatments for URTICARIA

URTICARIA treatment research studies

Mirtazapine clinical trials, surveys and public health registries

Find Drug Side Effect reports

Mirtazapine Side Effects

Completed Suicide (237)
Confusional State (206)
Hyponatraemia (180)
Depression (160)
Overdose (148)
Anxiety (147)
Fall (136)
Dizziness (130)
Agitation (130)
Condition Aggravated (123)
Somnolence (117)
Insomnia (113)
Headache (110)
Serotonin Syndrome (109)
Suicidal Ideation (107)
Fatigue (105)
Loss Of Consciousness (104)
Convulsion (103)
Aggression (103)
Suicide Attempt (100)
Nausea (96)
Oedema Peripheral (93)
Dyspnoea (92)
Weight Increased (90)
Tachycardia (90)
Tremor (84)
Malaise (82)
Vomiting (75)
Restless Legs Syndrome (75)
Myalgia (73)
Alanine Aminotransferase Increased (72)
Cardiac Arrest (71)
Inappropriate Antidiuretic Hormone Secretion (71)
Feeling Abnormal (70)
Toxicity To Various Agents (69)
Asthenia (69)
Diarrhoea (67)
Syncope (62)
Hyperhidrosis (61)
Neuroleptic Malignant Syndrome (61)
Pain In Extremity (61)
Electrocardiogram Qt Prolonged (60)
Pyrexia (59)
Aspartate Aminotransferase Increased (58)
Pulmonary Embolism (57)
Arthralgia (56)
Hypotension (56)
Irritability (56)
Pain (55)
Gait Disturbance (54)

➢ More

Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)

Recent Reviews

i have been on citalopram and amatripolineand fluxaitne i have been on 15mg of mirtazapine and tryed 30mg the doc has put me on 45mg and i asked if these tablets dont work what is next hes said shrink as i have tryed all the ones he said but i have

My symptoms were tired, weak, unable to sleep. Was prescribed half of a 15 MG Mirtazapine nightly to help me sleep. Has this drug been successful used as a sleeping aid?

The above comment is too stupid, I actually LOLed at you Pete... lol you gave it 2 days and your complaining about the side-effects? and on 15 mgs? LMAO!!! It takes couple weeks at least to cope with the side-effects; just like m

48 year old male, I have suffered depression all my life. Have used SSRI's for the last ten years with good but mixed results. Last year lost my job due to an episode where I ended up throwing my monitor across the office and have not been able to wo

After a nasty experience with citalapram i was advised by my doc to try mirtazapine and it has suitedme very well. only side effect i canreport is an appetite increase. However as i don't carry much weight that isnt a problem.&

Back pain

Been on 90mg mirtazapine for 6 years twice the recomended dose is this considered safe

Body covered in hives

Does mirtazapine have muscles side effects?

Hi, I have been on mittazapine for 10 days, sleepy , tierd all the time and slugish in response to conversation just horrid feel gastly , head ace, The worst went to bed 11pm took the 15mg pill, went to the loo at 3am and collapse

I am of 53 suffering with skin problem for several years. Doctors are unable to diagnose the exact problem. Some doctors say it is Urticaria, some say it is some sort of Eczema and so on. The currentphysician advised to

After a 1 week course of Trimethoprim 200mg. I developed mild thrush on day3, muscle weakness for 1 day on the day after completion of the course and, 3 days after completion generalised urticaria. Not sure if this is delayed sensitivity but I assu

After Precedex my son (2 year old) has urticaria since august 23 2010 nothing seems to cure him.

How long after being started on cephalexin can urticaria occur?

I am experiencing peri-orbital edema and urticaria after an hour of taking Flanax. I took this many times in the past but no reaction like this...

I am of 53 suffering with skin problem for several years. Doctors are unable to diagnose the exact problem. Some doctors say it is Urticaria, some say it is some sort of Eczema and so on. The currentphysician advised to take RONEX(Cetirizin

I took diprofas each year to severe allergy and urticaria (aczema) My question what is the minimum time (interval) between the each vial; because after 3-4 weeks the allergy will be retained back. At the same time Im suffering from severe alopec

Inchaos nos ps com hematomas na parte interior / artelhos de ambos os ps e urticria durante 15 dias . Tive que ir por trs vezes ao mdico e uma urgncias hospitalar . Fiquei com marcas raiadas em ambos os ps de derrame . Gastei muit

Severe urticaria and many skin problem

Terrible post nasal drip,insommnia and skin urticaria. Please help!!!!!!!!!!

URTICARIA Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Validation of an URTICARIA Control Test
Condition: Chronic URTICARIA
Outcome Measure: URTICARIA activity
2 Unknown  Evaluating for Contact Allergies in Patients With Chronic URTICARIA
Conditions: URTICARIA;   Patch Testing;   Dermatitis;   Allergy;   Contact Sensitization
Intervention: Procedure: Patch Testing
Outcome Measures: To identify contact allergens with patch testing in patients with chronic idiopathic URTICARIA living in the New England area.;   To determine if avoidance of contact allergens causes the resolution of chronic URTICARIA in those patients with positive patch test results.
3 Recruiting Profiling URTICARIA for the Identification of Subtypes
Conditions: Non-autoreactive Chronic Spontaneous URTICARIA;   Autoimmune Chronic Spontaneous URTICARIA;   Autoreactive, Non-autoimmune Chronic Spontaneous URTICARIA
Outcome Measures: Results of the ASST;   Results of a cell activating assay (BHRA);   Results of autoantibody-test (anti-IgE and anti-FcRI);   Results of URTICARIA activity score (UAS7);   Results of HRQoL scores (CU-Q2oL, DLQI);   Results of laboratory tests (Thyroid antibodies (anti-TPO +/- anti-thyreoglobulin); ANA; Rheumatoid factor; CRP; ESR; total IgE; T3,T4, TSH, diff BB, Helicobacter pylori stool antigen test or breath test; D-Dimer)
4 Recruiting Development of an URTICARIA Control Test
Condition: Chronic URTICARIA
Outcome Measure:
5 Recruiting Real-life Management and Therapeutic Outcome of Patients With Chronic Rhinitis and Chronic URTICARIA in Thailand
Conditions: Allergic Rhinitis;   Non-allergic Rhinitis;   Chronic URTICARIA
Outcome Measures: The recalcitrant symptoms of chronic rhinitis or chronic URTICARIA;   The correlation between symptom severity and quality of life
6 Not yet recruiting Study of the Effects of Chinese Herbal Medicine on Chronic URTICARIA
Condition: Chronic URTICARIA
Interventions: Drug: Chinese Herbal Medicine (CHM);   Drug: Placebo
Outcome Measures: Changes in symptom severity;   Improvement of sleep disturbance;   Changes of serologic markers for URTICARIA
7 Recruiting Efficacy and Safety of CRTH2 Antagonist AZD1981 in Chronic Idiopathic URTICARIA (CIU) Antihistamines
Condition: Chronic Idiopathic URTICARIA
Interventions: Drug: AZD1981;   Drug: Placebo
Outcome Measures: The change in diary-based clinical symptoms as measured by the URTICARIA Activity Score 7 (UAS7);   The number of participants with adverse events;   The ability of AZD1981 to inhibit PGD2-induced Eosinophil shape;   The quality of life benefit provided by treatment of refractory CIU with AZD1981 in CIU as assessed by a sleep interference scale and Dermatology Life Quality Index (DLQI)
8 Recruiting Methotrexate in the Treatment of Chronic Idiopathic URTICARIA
Condition: Chronic URTICARIA
Interventions: Drug: Methotrexate (Novatrex ®) + anti-H1;   Drug: Placebo + anti-H1
Outcome Measures: Number of patients with complete remission of URTICARIA at 18 weeks;   Tolerance : clinical and biological safety;   Efficacy of the treatment in improving symptoms : pruritus;   Persistency of the complete remission at 26 weeks;   Efficacy of the treatment in improving symptoms : outbreaks by week;   Efficacy of the treatment in improving symptoms : duration of lesions;   Efficacy of the treatment in improving quality of life;   Efficacy of the treatment in improving quality of sleep;   Efficacy of the treatment in improving facial/cervical URTICARIAl lesions
9 Unknown  The Efficacy and Safety of Desloratadine With Levocetirizine in Treatment of Chronic Idiopathic URTICARIA
Conditions: Chronic Idiopathic URTICARIA;   URTICARIA
Intervention: Drug: Denosin® and Xyzal®
Outcome Measures: To evaluate the change in average AM/PM reflective pruritus score from baseline recorded in the patient diaries during the first two weeks of treatment;   To evaluate the change in average AM/PM reflective pruritus score from baseline recorded in the subjects’ diaries over the 6 weeks.;   To evaluate the reflective average AM/PM scores for number of hives, size of largest hive, and total symptom score (sum of pruritus, number of hives, and size of largest hive scores).;   Average individual AM/PM instantaneous scores for pruritus, number of hives, and size of largest hive are also evaluated.;   AM instantaneous scores for pruritus, number of hives, and size of largest hive are also evaluated.;   PM instantaneous scores for pruritus, number of hives, and size of largest hive are also evaluated.;   PM reflective scores for pruritus, number of hives, and size of largest hive are also evaluated.;   The interference with sleep (AM reflective), and interference with daily activities (PM reflective) are other secondary efficacy outcomes.
10 Recruiting Dietary Treatment for Chronic URTICARIA
Conditions: Diet Modification;   Chronic URTICARIA
Interventions: Other: Treatment group (on low histamine diet);   Other: Well-balanced diet
Outcome Measures: The change in Mean Total Symptoms Score (MTSS) from baseline between groups;   the change in mean pruritus score (MPS) between treatment group and control group;   the change in mean number of wheals (MNW) between groups;   the change in global symptoms severity (GSS) by medical investigator between groups;   the comparison of area under the curve (AUC for the trend) for MTSS, MPS, MNW, GSS and DCS between the groups during the 4-week period
11 Recruiting Effect of Omalizumab (Xolair) on Basophils in Patients With Chronic Idiopathic URTICARIA
Condition: Chronic URTICARIA
Intervention: Drug: Omalizumab
Outcome Measures: Change in the basophil proteome;   Change in basophil proteome in responders to omalizumab compared to non-responders to omalizumab
12 Recruiting Pathogenesis of Physical Induced URTICARIAl Syndromes
Conditions: Autoinflammatory Syndromes;   Physical URTICARIA
Outcome Measure:
13 Recruiting Efficacy Study of Omalizumab in Cholinergic URTICARIA
Condition: Cholinergic URTICARIA
Interventions: Biological: Active;   Biological: Placebo;   Biological: Open labeled
Outcome Measures: Negativization of the exercise challenge test;   Quality of life;   Patients' card;   Treatment drop offs in each sequence
14 Recruiting T Cell Function in Chronic Idiopathic URTICARIA
Condition: Chronic URTICARIA
Outcome Measure:
15 Recruiting Cold URTICARIA Treatment With Xolair
Condition: Cold Contact URTICARIA
Interventions: Drug: Omalizumab;   Drug: Placebo
Outcome Measures: Change in critical temperature thresholds (CTT) from baseline to day 70 after treatment with omalizumab compared to placebo;   Safety of patients treated with omalizumab: This includes physical examination, routine safety laboratory assessments, vital signs and adverse event reporting
16 Recruiting Efficacy Study of Canakinumab to Treat URTICARIA
Condition: Chronic Idiopathic URTICARIA
Interventions: Drug: Canakinumab;   Drug: Placebo
Outcome Measure: Complete clinical remission
17 Unknown  The Efficacy of a Pseudoallergen-Free Diet in the Treatment of Chronic Idiopathic URTICARIA and/or Angioedema
Conditions: URTICARIA;   Angioedema
Intervention: Behavioral: Dietary Therapy
Outcome Measures: The frequency and severity of CIU and/or angioedema (as determined via a five point rating scale);   The relative use of antihistamines (ie how many, how often)
18 Recruiting Multicenter Pilot Phase III Clinical Trials of JDP-205 iv Injection for the Treatment of Acute URTICARIA Associated With an Acute Allergic Reaction.
Condition: Acute URTICARIA
Interventions: Drug: JDP-205 Injection;   Drug: Diphenhydramine
Outcome Measure: Change of Extent of URTICARIA symptom score
19 Not yet recruiting Platelet Activation in Chronic Inflammatory Skin Diseases
Conditions: URTICARIA;   Atopic Dermatitis
Intervention: Procedure: Blood sampling
Outcome Measures: Platelet activation;   Mean platelet volume
20 Recruiting Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease
Conditions: Nervous System Malformations;   Arthropathy, Neurogenic;   URTICARIA;   Papilledema
Outcome Measure: Comparison of group mean of total disease diary score before compared to after treatment (3-4 mo); mean change in the area under the curve in SAA in patients before and 3-4 mo after tx as well as before and after drug withdrawal.